(HealthDay News) — Insulin pump therapy is more effective than multiple daily injections (MDI) for glycemic control in patients with type 2 diabetes, according to a study published online in Diabetes, ...

Use of an insulin pump with a sensor that suspends insulin delivery when blood glucose falls below a set threshold reduced the rate of severe and moderate hypoglycemia among patients with type 1 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with type 1 diabetes who used an automated ...

While 9 out of 10 people with diabetes are living with T2D, many of the automated insulin delivery solutions currently on the market were designed for people living with T1D. 300-unit insulin ...

The MarketWatch News Department was not involved in the creation of this content.-- Study assessing PharmaSens all-in-one insulin patch pump provides first evidence that combining ...

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today presented ...

The Insulin Pump Therapy Program continues its treatment for Alberta, Canada citizens with Type 1 Diabetes, says a new development in the case. It will not cease its operations and offers for its ...

The possible advantage of hybrid closed-loop therapy (i.e., artificial pancreas) over sensor-augmented pump therapy in very young children with type 1 diabetes is unclear. In this multicenter, ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded label for rapid-acting insulin lispro-aabc injection to include administration via ...

IRVINE, Calif.--(BUSINESS WIRE)--Medical device developer Capillary Biomedical, Inc. (CapBio) has announced that it has received investigational device exemption (IDE) approval from the U.S. Food and ...